Ironwood Pharmaceuticals, Inc. IRWD

4.13 (0.06) (1.43%) as of 25 Sep
Market cap
$692.4M
P/E
5.2×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
215.46 88.56 92.15 657.45 621.38 364.30 178.27 174.42 221.42 305.22
Receivables
46.75 81.89 129.12 115.46 114.04 122.35 117.25 80.95 82.16 64.85
Inventory
— — — — — 0.65 0.65 (0.81) 0.74 1.08
Other current assets
— — — 8.00 1.12 9.00 11.00 11.00 7.00 9.03
Total current assets
274.18 182.37 233.29 780.63 745.23 495.84 306.85 266.44 311.60 380.18
Property, Plant, Equpment (Net)
3.41 4.50 5.59 6.29 7.58 8.93 12.43 7.65 17.27 20.51
Long-term receivables
— — — 14.59 24.00 23.40 32.60 — — —
Goodwill and Intangible Assets (Total)
2.04 2.86 3.68 — — — 1.00 0.79 160.69 166.90
Long Term Assets (Tax, Deferred)
103.43 144.23 212.32 283.66 333.29 — — — — —
Long-term assets (Other)
4.50 5.92 3.61 1.33 1.49 14.49 33.13 47.54 116.11 142.22
Total non-current assets
122.72 168.54 237.79 319.89 381.70 63.40 95.90 65.62 294.08 329.64
Total Assets
396.90 350.91 471.07 1,100.52 1,126.93 559.24 402.75 332.05 605.67 709.82
Accounts Payable
2.90 2.13 7.83 0.48 0.94 0.66 5.49 14.89 15.96 17.70
Accrued Expenses
36.39 33.53 65.59 21.96 39.46 28.38 33.42 40.96 45.55 45.24
Current Part of Debt
199.68 — 199.56 3.00 116.86 3.00 1.00 47.55 4.00 6.23
Current Part of Capital Lease
— — — — — — — 0.07 4.08 6.23
Current Revenue (Deferred)
— — — — — 0.00 0.88 0.25 0.20 7.72
Other current liabilities
— — — 0.02 1.32 28.00 34.00 0.05 0.25 14.24
Total current liabilities
242.22 38.85 276.10 25.53 161.70 32.17 40.93 119.52 66.03 91.13
Long Term Debt (Total)
385.00 583.99 498.31 396.25 356.00 430.26 407.99 366.30 396.09 366.57
Non-current Revenue (Deferred)
— — — — — — — 6.31 5.45 0.56
Non-current Liabilities (Other)
21.65 17.11 28.42 9.77 340.83 13.85 24.99 36.29 128.26 184.84
Total non-current liabilities
416.52 613.40 541.27 422.62 359.32 464.43 455.07 408.90 529.80 551.97
Total liabilities
658.74 652.24 817.37 448.14 521.02 496.60 496.00 528.42 595.83 643.11
Additional Paid In Capital
1,412.78 1,395.32 1,355.20 1,348.60 1,543.36 1,528.54 1,478.82 1,394.60 1,318.54 1,258.40
Common Stock (Net)
0.16 0.16 0.16 0.15 0.16 0.16 0.16 0.15 0.15 0.15
Retained Earnings
(1,673.72) (1,697.73) (1,698.61) (696.38) (937.61) (1,466.06) (1,572.23) (1,591.13) (1,308.76) (1,191.82)
Common Equity (Total)
(261.83) (301.33) (346.29) 652.38 605.91 62.64 (93.25) (196.37) 9.85 66.72
Shareholders Equity (Total)
(261.83) (301.33) (346.29) 652.38 605.91 62.64 (93.25) (196.37) 9.85 66.72
Shareholders Equity and Liabilities (Total)
396.90 350.91 471.07 1,100.52 1,126.93 559.24 402.75 332.05 605.67 709.82
Shares (Common)
163.06 160.21 156.35 154.03 162.04 160.62 157.54 154.42 150.45 147.12
Shareholders Equity (Tangible)
(263.87) (304.19) (349.98) 652.38 605.91 62.64 (93.25) (197.16) (150.84) (100.19)
Net Debt
369.22 495.43 605.72 (258.20) (148.52) 68.96 230.72 239.43 178.68 67.59
Total Debt
584.68 583.99 697.87 399.25 472.86 433.26 408.99 413.85 400.09 372.80

Fold the line items

In millions of $ except per-share values · columns are period end dates